Paul Huchedé | Oncology | Young Scientist Award

Young Scientist Award

Paul Huchedé
Institute Pasteur
Paul Huchedé
Affiliation Institute Pasteur
Country New Caledonia
Scholar ID XY3a6AYAAAAJ
Documents 16
Citations 141
h-index 5
Subject Area Oncology
Event Global Scientist Day Awards

Paul Huchedé of Institute Pasteur has established a growing research profile in oncology through scholarly publications, citation performance, and contributions to cancer-related scientific investigations. His academic accomplishments reflect active participation in advancing biomedical knowledge and supporting innovation within oncology research.[1]

Abstract

Paul Huchedé is an oncology researcher whose scholarly activities contribute to understanding mechanisms, diagnostics, and therapeutic approaches associated with cancer research. His publication portfolio, citation record, and academic engagement demonstrate an emerging influence within the biomedical sciences. The available scholarly indicators suggest a research trajectory characterized by scientific productivity, interdisciplinary collaboration, and commitment to advancing oncology-related knowledge.[1]

Keywords

Young Scientist Award, Oncology, Cancer Research, Biomedical Science, Scientific Publications, Research Impact, Translational Medicine, Academic Excellence, Emerging Researcher, Global Scientist Day Awards.

Introduction

Oncology is a rapidly evolving scientific discipline focused on understanding cancer biology, improving diagnostic methodologies, and developing effective therapeutic interventions. Researchers in this field contribute significantly to public health through discoveries that enhance disease prevention, treatment outcomes, and patient care. Paul Huchedé’s academic profile reflects active involvement in this important area of research and aligns with the broader objectives of scientific advancement in oncology.[1]

Research Profile

Paul Huchedé is affiliated with Institute Pasteur and has established a measurable academic presence through peer-reviewed publications and citation activity. His Google Scholar profile records sixteen scholarly documents, one hundred forty-one citations, and an h-index of five. These metrics indicate ongoing participation in scientific research and increasing visibility within the oncology research community.[1]

  • Research Area: Oncology
  • Affiliation: Institute Pasteur
  • Scholar Documents: 16
  • Total Citations: 141
  • h-index: 5

Research Contributions

The scholarly work of Paul Huchedé contributes to oncology research through scientific investigations that support the understanding of cancer-related biological processes and clinical applications. His research outputs have contributed to the broader scientific dialogue surrounding cancer diagnosis, treatment strategies, and translational biomedical science. Such contributions are important for fostering evidence-based advancements within healthcare and oncology research communities.[1]

  • Participation in peer-reviewed oncology research.
  • Contribution to biomedical and translational science.
  • Support for cancer-related scientific investigations.
  • Advancement of evidence-based medical research.
  • Collaboration within multidisciplinary scientific initiatives.

Publications

The publication record of Paul Huchedé consists of peer-reviewed scholarly works that contribute to the oncology literature. His research outputs have been disseminated through recognized academic channels, enabling scientific findings to reach researchers, clinicians, and healthcare professionals. Publication activity remains a key indicator of scholarly engagement and scientific productivity.[1]

  • Peer-reviewed oncology publications.
  • Biomedical research articles.
  • Scientific studies contributing to cancer research literature.

Research Impact

Research impact is commonly evaluated through scholarly visibility, publication influence, and citation performance. Paul Huchedé’s citation record demonstrates that his research findings have been referenced by other investigators, indicating relevance within the scientific community. Such metrics support the assessment of academic influence while complementing qualitative evaluations of research significance and innovation.[1]

Research Metric Value
Documents 16
Citations 141
h-index 5

Award Suitability

The Young Scientist Award is intended to recognize researchers who demonstrate notable promise and measurable academic achievement during the early phases of their scientific careers. Based on available scholarly indicators, Paul Huchedé exhibits characteristics consistent with this recognition, including publication productivity, citation impact, and engagement in oncology research. These attributes support consideration for recognition within the Global Scientist Day Awards program.[1]

Conclusion

Paul Huchedé has established a developing academic profile characterized by meaningful contributions to oncology research and measurable scholarly influence. Through peer-reviewed publications, citation performance, and continued engagement in biomedical investigations, he contributes to scientific understanding within the field of cancer research. His accomplishments align with the objectives of the Young Scientist Award, which recognizes emerging researchers demonstrating excellence, innovation, and future potential.[1]

References

  1. Google Scholar. (n.d.). Scholar profile details: Paul Huchedé, Scholar ID XY3a6AYAAAAJ. https://scholar.google.com/citations?user=XY3a6AYAAAAJ&hl=en&oi=sra
  2. Cancer Research Publishing Standards. (n.d.). DOI Reference Example for Scholarly Publications. https://doi.org/10.1038/s41586-020-2649-2
  3. Global Scientist Day Awards. (n.d.). Awards Program and Academic Recognition Information. https://scientistday.org/

Haishan Jiang | Medical Discoveries | Innovation in Science Award

Dr. Haishan Jiang | Medical Discoveries | Innovation in Science Award 

Dr. Haishan Jiang, Southern Medical University, China

Dr. Haishan Jiang, Chief Physician and Associate Professor at Southern Medical University’s Nanfang Hospital, is a leading expert in neurology, specializing in myopathy, peripheral neuropathy, and rare neurological diseases. As Deputy Director of the Neurology Department and head of the Myopathy and Peripheral Neuropathy subspecialty, he has pioneered gene therapies for SMA and ALS in South China. His research focuses on motor neuron and mitochondrial diseases, as well as gene therapy for rare conditions. Widely recognized, Dr. Jiang has been honored as the “Good Doctor of Guangzhou” and ranks top nationally in physician recommendations for multiple rare diseases.

Author Profile

ORCID

🧑‍🎓 Early Academic Pursuits

Dr. Haishan Jiang embarked on his medical journey with a deep-rooted commitment to understanding the complexities of the human nervous system. With a Doctor of Medicine degree and solid academic grounding, he demonstrated early on a keen interest in neurology, particularly in the areas of myopathy and peripheral neuropathy. His academic path was marked by diligence, a sharp scientific mind, and a profound dedication to uncovering the underlying mechanisms of rare neurological diseases. As a postgraduate supervisor, Dr. Jiang has also shown a strong passion for nurturing the next generation of medical professionals, sharing his knowledge and guiding their research pursuits with patience and precision.

🩺 Professional Endeavors

Currently serving at Nanfang Hospital of Southern Medical University, Dr. Jiang holds several key positions: Chief Physician, Associate Professor, Deputy Director of the Neurology Department, Director of Teaching, and Head of the Myopathy and Peripheral Neuropathy subspecialty. His clinical expertise spans a wide spectrum of neurological disorders, with a particular emphasis on difficult and rare conditions such as motor neuron disease (ALS), mitochondrial encephalomyopathy, and adult-onset spinal muscular atrophy (SMA). Dr. Jiang’s commitment to clinical excellence has led him to establish and lead the Guangdong Province Myopathy and Peripheral Nerve Specialized Alliance, a network aimed at advancing diagnosis, treatment, and research collaboration. Under his leadership, the department ranks among the top two nationally in terms of annual muscle and nerve biopsy volume, solidifying its reputation as a hub for neuromuscular disease care.

🧬 Contributions and Research Focus

Dr. Jiang’s research interests are firmly rooted in neurogenetic disorders, particularly motor neuron diseases (ALS) and mitochondrial disorders. His work seamlessly blends basic science with clinical application, focusing on understanding disease mechanisms and exploring cutting-edge gene therapy approaches. He has spearheaded some of South China’s most advanced gene therapy trials, including the region’s first gene therapy for adult SMA—the fourth such case in the country—and the first ALS gene therapy clinical trial in South China, also the second nationwide. His pioneering research not only contributes to academic knowledge but also offers hope to patients battling previously untreatable conditions. Through his clinical studies, Dr. Jiang is pushing the frontiers of personalized medicine, bringing precision diagnostics and therapy into the mainstream for rare and complex neurological diseases.

🏅 Accolades and Recognition

Dr. Haishan Jiang’s unwavering dedication to medical science and patient care has earned him widespread acclaim. Notably, he was honored as the sixth “Good Doctor of Guangzhou” and selected as part of the ninth batch of “Outstanding Provincial and Municipal Talents Supporting Xinjiang”, a testament to both his clinical excellence and humanitarian spirit. Furthermore, he was recognized by the Good Doctor Network as an “Annual Good Doctor” for his exceptional service in rare disease diagnosis and treatment. His reputation as a leading clinician is reflected in his top rankings in national physician recommendation lists—first place for 13 diseases, including ALS and mitochondrial encephalomyopathy, and second place for 15 others. These accolades not only highlight his expertise but also the trust he has earned from patients and peers alike.

🌍 Impact and Influence

Dr. Jiang’s work has had a transformative impact on neurology in China, particularly in the realm of rare diseases. By advancing the use of gene therapy and establishing regional alliances, he has created a robust infrastructure for collaboration, research, and clinical care. His contributions have significantly improved diagnostic timelines and therapeutic options for patients who previously faced long diagnostic odysseys and limited treatment possibilities. As a teacher and mentor, Dr. Jiang has shaped the careers of countless postgraduate students and young doctors, many of whom now contribute to clinical neurology and research across the country. His influence extends beyond the clinic to policy and advocacy, where he is a strong voice for the rare disease community.

🔬 Legacy and Future Contributions

Dr. Haishan Jiang stands at the forefront of a new era in neurology, where genomics and personalized medicine are reshaping how we understand and treat complex diseases. His legacy is already evident in the systems he has built, the patients he has helped, and the students he has inspired. Looking ahead, Dr. Jiang aims to further expand gene therapy applications, develop innovative treatment protocols, and foster international collaboration in rare disease research. With his continued focus on combining scientific rigor with compassionate care, Dr. Jiang is set to leave a lasting legacy in Chinese and global neurology. His work is not only rewriting the medical narrative for patients with rare conditions but also paving the way for future breakthroughs in neuroscience.

✍️ Publication Top Notes


📘A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Author: Xujun Chu; Juan Kang; Jingwen Xu; Haishan Jiang; Zhi‐Ying Wu; Qingping Wang; Wei Li; Jia Li;
Journal: Annals of Neurology
Year:2025

📘Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis

Author: Jian Qin; Ye He; Weiyi Yu; Zhaoyong Zhang; Xiaodan Chen; Yafang Hu; Haishan Jiang
Journal: Archives of Biochemistry and Biophysics
Year: 2025

📘Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Author: Yeli Zhu; Jingxian Fan; Xiying Zhu; Wei Li; Zhaoyong Zhang; Hui Zheng; Zhihua Zhou; Lingchao Meng; Ruxu Zhang; Haishan Jiang
Journal: Orphanet Journal of Rare Diseases
Year: 2025